Directing degradation

By Edyta Zielinska Directing degradation Serhiy Pankiv The paper: S. Pankiv et al., “p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy,” J Biol Chem , 282:24131–45, 2007. (Cited in 113 papers) The finding: Terje Johansen and his colleagues at the University of Tromsø, Norway, discovered the specific molecule involved in targeting cellular waste for d

Written byEdyta Zielinska
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The paper:

S. Pankiv et al., “p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy,” J Biol Chem , 282:24131–45, 2007. (Cited in 113 papers)

The finding:

Terje Johansen and his colleagues at the University of Tromsø, Norway, discovered the specific molecule involved in targeting cellular waste for destruction via large double-membrane vesicles called autophagosomes. They found that the protein p62 binds both the ubiquitin-tagged trash and the light chain 3 (LC3) protein on the outside of the autophagosomal membrane. “It was the first paper that showed how directed autophagy might work,” says Vladimir Kirkin of the Johann Wolfgang Goethe University in Frankfurt, Germany.

The bonus:

p62 is also crucial for another process key to cellular cleanup: the clumping together of misfolded proteins before they are engulfed by autophagosomes. Not only does it traffic the aggregate to the right place, “p62 also catalyzes this gluing,” ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies